10q10k10q10k.net
ROCKET PHARMACEUTICALS, INC.

ROCKET PHARMACEUTICALS, INC.RCKTW決算レポート

Nasdaq
Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023

RCKTW Q3 2025 Key Financial Metrics

売上高

$0

粗利益

N/A

営業利益

$-52.2M

純利益

$-50.3M

粗利益率

N/A

営業利益率

N/A

純利益率

N/A

前年比成長

N/A

EPS

$-0.45

ROCKET PHARMACEUTICALS, INC. Q3 2025 財務サマリー

ROCKET PHARMACEUTICALS, INC. reported revenue of $0 for Q3 2025, with a net profit of $-50.3M (up 24.6% YoY) (N/A margin). Cost of goods sold was N/A.

主要財務指標

総売上高$0
純利益$-50.3M
粗利益率N/A
営業利益率N/A
報告期間Q3 2025

ROCKET PHARMACEUTICALS, INC. 年度売上推移

ROCKET PHARMACEUTICALS, INC. annual revenue history includes year-by-year totals (for example, 2022 revenue was $0). Click any linked year to see what changed vs the prior 10-K.

年度年間売上
2022$0—

ROCKET PHARMACEUTICALS, INC. 四半期売上・純利益の履歴

ROCKET PHARMACEUTICALS, INC. quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

四半期売上高売上前年比純利益純利益率
Q3 2025$0—$-50.3MN/A
Q2 2025$0—$-68.9MN/A
Q1 2025$0—$-61.3MN/A
Q3 2024$0—$-66.7MN/A
Q2 2024$0—$-69.6MN/A
Q1 2024$0—$-62.1MN/A
Q3 2023$0—$-61.9MN/A
Q2 2023$0—$-65.7MN/A

損益計算書

Q2 2023Q3 2023Q1 2024Q2 2024Q3 2024Q1 2025Q2 2025Q3 2025
売上高$0$0$0$0$0$0$0$0
前年比成長N/AN/AN/AN/AN/AN/AN/AN/A

貸借対照表

Q2 2023Q3 2023Q1 2024Q2 2024Q3 2024Q1 2025Q2 2025Q3 2025
総資産$461.8M$598.8M$499.4M$446.4M$393.7M$471.1M$421.0M$368.0M
総負債$58.8M$57.7M$57.9M$61.8M$63.9M$58.9M$66.8M$54.4M
株主資本$403.0M$541.1M$441.5M$384.6M$329.8M$412.1M$354.2M$313.7M

キャッシュフロー

Q2 2023Q3 2023Q1 2024Q2 2024Q3 2024Q1 2025Q2 2025Q3 2025
営業CF$-50.9M$-57.1M$-56.9M$-53.8M$-52.1M$-55.8M$-49.0M$-50.4M